Skip to content

Intention survey of anti-VEGF treatment on patients with Diabetic Retinopathy

Intention survey of anti-VEGF treatment on patients with Diabetic Retinopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027491
Enrollment
Unknown
Registered
2019-11-15
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy

Interventions

Case Series:N/A

Sponsors

The Fourth Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with diabetic retinopathy and macular edema. 2.Patients with proliferative diabetic retinopathy without macular edema.

Exclusion criteria

Exclusion criteria: Patients with severe vitreous hemorrhage that cannot be absorbed, retinal detachment, severe preretinal proliferative membrane, who require surgical treatment.

Design outcomes

Primary

MeasureTime frame
treatment intention;

Countries

China

Contacts

Public ContactJun Kong

The Fourth Affiliated Hospital of China Medical University

kongjun@hotmail.com+86 13066521123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026